164 related articles for article (PubMed ID: 33076905)
1. High Smad7 in the early post-operative recurrence of Crohn's disease.
Zorzi F; Calabrese E; Di Fusco D; De Cristofaro E; Biancone L; Casella S; Palmieri G; Monteleone G
J Transl Med; 2020 Oct; 18(1):395. PubMed ID: 33076905
[TBL] [Abstract][Full Text] [Related]
2. Distinct profiles of effector cytokines mark the different phases of Crohn's disease.
Zorzi F; Monteleone I; Sarra M; Calabrese E; Marafini I; Cretella M; Sedda S; Biancone L; Pallone F; Monteleone G
PLoS One; 2013; 8(1):e54562. PubMed ID: 23349929
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal Regulation Between Smad7 and Sirt1 in the Gut.
Sedda S; Franzè E; Bevivino G; Di Giovangiulio M; Rizzo A; Colantoni A; Ortenzi A; Grasso E; Giannelli M; Sica GS; Fantini MC; Monteleone G
Front Immunol; 2018; 9():1854. PubMed ID: 30147698
[TBL] [Abstract][Full Text] [Related]
4. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.
Monteleone G; Kumberova A; Croft NM; McKenzie C; Steer HW; MacDonald TT
J Clin Invest; 2001 Aug; 108(4):601-9. PubMed ID: 11518734
[TBL] [Abstract][Full Text] [Related]
5. Smad7 Knockdown Restores Aryl Hydrocarbon Receptor-mediated Protective Signals in the Gut.
Monteleone I; Marafini I; Zorzi F; Di Fusco D; Dinallo V; Rizzo A; Sileri P; Sica G; Monteleone G
J Crohns Colitis; 2016 Jun; 10(6):670-7. PubMed ID: 26818761
[TBL] [Abstract][Full Text] [Related]
6. CCL20 Is Negatively Regulated by TGF-β1 in Intestinal Epithelial Cells and Reduced in Crohn's Disease Patients With a Successful Response to Mongersen, a Smad7 Antisense Oligonucleotide.
Marafini I; Monteleone I; Dinallo V; Di Fusco D; De Simone V; Laudisi F; Fantini MC; Di Sabatino A; Pallone F; Monteleone G
J Crohns Colitis; 2017 May; 11(5):603-609. PubMed ID: 28453765
[TBL] [Abstract][Full Text] [Related]
7. Tissue inhibitor of metalloproteinase-3 regulates inflammation in human and mouse intestine.
Monteleone I; Federici M; Sarra M; Franzè E; Casagrande V; Zorzi F; Cavalera M; Rizzo A; Lauro R; Pallone F; MacDonald TT; Monteleone G
Gastroenterology; 2012 Nov; 143(5):1277-1287.e4. PubMed ID: 22819866
[TBL] [Abstract][Full Text] [Related]
8. Smad7 and its Potential as Therapeutic Target in Inflammatory Bowel Diseases.
Laudisi F; Dinallo V; Di Fusco D; Monteleone G
Curr Drug Metab; 2016; 17(3):303-6. PubMed ID: 26651974
[TBL] [Abstract][Full Text] [Related]
9. Involvement of Smad7 in Inflammatory Diseases of the Gut and Colon Cancer.
Troncone E; Marafini I; Stolfi C; Monteleone G
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920230
[TBL] [Abstract][Full Text] [Related]
10. Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote Colitis.
Tang Y; Reissig S; Glasmacher E; Regen T; Wanke F; Nikolaev A; Gerlach K; Popp V; Karram K; Fantini MC; Schattenberg JM; Galle PR; Neurath MF; Weigmann B; Kurschus FC; Hövelmeyer N; Waisman A
Gastroenterology; 2019 Feb; 156(3):692-707.e7. PubMed ID: 30315770
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of Smad7 With a Specific Antisense Oligonucleotide Attenuates Colitis and Colitis-Driven Colonic Fibrosis in Mice.
Izzo R; Bevivino G; De Simone V; Sedda S; Monteleone I; Marafini I; Di Giovangiulio M; Rizzo A; Franzè E; Colantoni A; Ortenzi A; Monteleone G
Inflamm Bowel Dis; 2018 May; 24(6):1213-1224. PubMed ID: 29668937
[TBL] [Abstract][Full Text] [Related]
12. TGF-Beta signaling manipulation as potential therapy for IBD.
Marafini I; Zorzi F; Codazza S; Pallone F; Monteleone G
Curr Drug Targets; 2013 Nov; 14(12):1400-4. PubMed ID: 23489130
[TBL] [Abstract][Full Text] [Related]
13. High Smad7 sustains inflammatory cytokine response in refractory coeliac disease.
Sedda S; De Simone V; Marafini I; Bevivino G; Izzo R; Paoluzi OA; Colantoni A; Ortenzi A; Giuffrida P; Corazza GR; Vanoli A; Di Sabatino A; Pallone F; Monteleone G
Immunology; 2017 Mar; 150(3):356-363. PubMed ID: 27861825
[TBL] [Abstract][Full Text] [Related]
14. The TGF-β/Smad System in IBD Pathogenesis.
Sedda S; Marafini I; Dinallo V; Di Fusco D; Monteleone G
Inflamm Bowel Dis; 2015 Dec; 21(12):2921-5. PubMed ID: 26230862
[TBL] [Abstract][Full Text] [Related]
15. High SMAD7 and p-SMAD2,3 expression is associated with environmental enteropathy in children.
Syed S; Dinallo V; Iqbal NT; Di Iorio L; Di Fusco D; Guleria S; Amadi BC; Sadiq K; Moskaluk C; Ali SA; Kelly P; Monteleone G
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006224. PubMed ID: 29415065
[TBL] [Abstract][Full Text] [Related]
16. Enrichment of Circulating and Mucosal Cytotoxic CD8+ T Cells Is Associated with Postoperative Endoscopic Recurrence in Patients with Crohn's Disease.
Boschetti G; Nancey S; Moussata D; Cotte E; Francois Y; Flourié B; Kaiserlian D
J Crohns Colitis; 2016 Mar; 10(3):338-45. PubMed ID: 26589954
[TBL] [Abstract][Full Text] [Related]
17. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
18. Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression.
Fantini MC; Rizzo A; Fina D; Caruso R; Sarra M; Stolfi C; Becker C; Macdonald TT; Pallone F; Neurath MF; Monteleone G
Gastroenterology; 2009 Apr; 136(4):1308-16, e1-3. PubMed ID: 19192480
[TBL] [Abstract][Full Text] [Related]
19. Role of Smad7 in inflammatory bowel diseases.
Monteleone G; Caruso R; Pallone F
World J Gastroenterol; 2012 Oct; 18(40):5664-8. PubMed ID: 23155305
[TBL] [Abstract][Full Text] [Related]
20. Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease.
Monteleone G; Del Vecchio Blanco G; Monteleone I; Fina D; Caruso R; Gioia V; Ballerini S; Federici G; Bernardini S; Pallone F; MacDonald TT
Gastroenterology; 2005 Nov; 129(5):1420-9. PubMed ID: 16285943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]